Disclosure of conflicts of interest in biomedical publications.
作者信息
Miller Donald R
出版信息
Can J Anaesth. 2008 May;55(5):265-7, 267-9. doi: 10.1007/BF03017202.
PMID:18451113
Abstract
摘要
相似文献
1
Disclosure of conflicts of interest in biomedical publications.
Can J Anaesth. 2008 May;55(5):265-7, 267-9. doi: 10.1007/BF03017202.
2
Editorial policies on financial disclosure.
Nat Neurosci. 2003 Oct;6(10):1001. doi: 10.1038/nn1003-1001.
3
Financial disclosure for review authors.
Nat Neurosci. 2003 Oct;6(10):997. doi: 10.1038/nn1003-997.
4
Editorial policies on financial disclosure.
Nat Neurosci. 2003 Oct;6(10):999-1000; author reply 1000-1. doi: 10.1038/nn1003-999.
5
[Conflicts of interest--an evidence-based approach].
Tidsskr Nor Laegeforen. 2012 Jun 12;132(11):1358-60. doi: 10.4045/tidsskr.12.0380.
6
Conflicts of interest at the NIH--resolving the problem.
N Engl J Med. 2004 Sep 2;351(10):955-7. doi: 10.1056/NEJMp048235.
7
Conflict of interest.
Trends Endocrinol Metab. 2006 Dec;17(10):379. doi: 10.1016/j.tem.2006.10.002. Epub 2006 Oct 18.
8
Declaration of conflicts of interest in scientific publications.
World J Biol Psychiatry. 2009;10(1):2-5. doi: 10.1080/15622970802685032.
9
Comment on: developing good scientific publishing practices: one pharmaceutical company's perspective.
Curr Med Res Opin. 2010 Jul;26(7):1675-6. doi: 10.1185/03007995.2010.487418.
10
All above board: openness is the only option if science is to maintain its integrity.
New Sci. 2004;181(2437):3.
Zotero 插件